

Fundamental dimension Equity attribute | BRSPPeer $3.66▲+0.27% Cap $463.1MP/E -15.8x QuantScore42/100 | AHHPeer $6.76▲+1.05% Cap $541.8MP/E -26.0x QuantScore36/100 | CTOLeader $19.78▼-2.32% Cap $741.5MP/E 13.9x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
36/100 |
32/100 |
35/100 |
Valuation Multiples, PEG & DCF upside | 60/100 | 75/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 13/100 | 27/100 | 43/100 |
Growth Revenue / earnings growth & margins | 30/100 | 5/100 | 58/100 |
Sentiment Analyst ratings, targets & revisions | 68/100 | 43/100 | 73/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -15.8x | -26.0x | 13.9x |
Forward P/E (next FY) | 6.8x | -10.1x | 21.2x |
EV / EBITDA (TTM) | 40.1x | 3.3x | 11.6x |
Price / Sales | 1.4x | 2.0x | 4.6x |
Price / Free Cash Flow | 5.4x | 8.6x | 52.3x |
PEG ratio | 0.77 | -0.05 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 4 / 9 | 6 / 9 |
Altman Z-Score | -0.52 (Distress) | 0.56 (Distress) | 1.05 (Distress) |
Total debt / equity | 3.20 | 0.00 | 1.04 |
Quick ratio | 1.0x | — | 2.4x |
Interest coverage | 0.5x | 1.5x | 2.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -4.5% | -59.7% | +20.1% |
Net income growth YoY | +76.4% | -84.3% | +613.6% |
Gross margin (TTM) | 43.2% | 32.2% | 0.6% |
Operating margin (FY) | 39.5% | 28.7% | 22.1% |
FCF margin (FY) | 22.0% | 5.8% | 43.2% |
5. Trailing price performancePrice change over period |
1M return | -10.5% | -0.3% | -3.7% |
3M return | -30.0% | +20.9% | -10.1% |
6M return | -39.6% | +1.8% | +0.6% |
Year to date | -34.6% | +2.1% | +7.4% |
1Y return | -30.9% | -2.2% | +20.8% |
3Y return | -32.3% | -43.0% | +25.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $10.34 +182.6% upside | $31.67 +368.5% upside | $92.10 +365.6% upside |
Wall Street consensus target | $5.00 +36.6% · range $4.00–$6.00 | $8.25 +22.0% · range $7.50–$9.00 | $24.67 +24.7% · range $24.00–$25.00 |
Consensus stance | 67% Buy11% Hold22% Sell | 43% Buy50% Hold7% Sell | 90% Buy10% Hold0% Sell |